- 期刊
- OpenAccess
Progesterone for Luteal Phase Support in In Vitro Fertilization: Comparison of Vaginal and Rectal Pessaries to Vaginal Capsules: A Randomized Controlled Study
摘要
BACKGROUND: In IVF, Luteal phase support is usually performed using vaginal progesterone. A part of patients using this route reports being uncomfortable with this route. We tried to study whether the rectal route could be an effective alternative and associated with less discomfort. PATIENTS AND METHODS: A prospective randomized controlled study. All patient were eligible for IVF treatment for infertility. After oocyte pickup, 186 patients were allocated to one the following protocols for luteal phase support: (i) rectal pessaries group: natural progesterone pessaries administered rectally 200 mg three times a day, (ii) vaginal pessaries group: natural progesterone pessaries administered vaginally 200 mg three times a day), and (iii) vaginal capsules group: natural micronized progesterone capsules administered vaginally 200 mg three times a day. On the day of pregnancy test, patients were asked to fill in a questionnaire conducted by an investigator in order to assess the tolerability and side effects of the LPS treatment taken. The primary endpoint was the occurrence of perineal irritation. RESULTS: Fifty eight patients were assigned to the rectal pessaries group, 68 patients to the vaginal pessaries group, and 60 patients to the vaginal capsules group. All patients adhered to their allocated treatment. Implantation and clinical pregnancy rates per transfer did not differ between the three groups. Perineal irritation, which was our primary endpoint, was the same for all the three groups (respectively 1.7 % versus 5.9 % versus 11.7%). Regarding the other side effects, more patients experienced constipation and flatulence with the rectal route, whereas more patients reported vaginal discharge in the vaginal capsules group. CONCLUSION: Rectal administration for luteal phase support is effective and well accepted alternative to vaginal route.
延伸閱讀
- Balkus, J., Agnew, K., Lawler, R., Mitchell, C., & Hitti, J. (2010). Effects of Pregnancy and Bacterial Vaginosis on Proinflammatory Cytokine and Secretory Leukocyte Protease Inhibitor Concentrations in Vaginal Secretions. Journal of Pregnancy, 2010(), 30-32. https://doi.org/10.1155/2010/385981
- Smayevsky, J., Canigia, L. F., Lanza, A., & Bianchini, H. (2001). Vaginal microflora associated with bacterial vaginosis in nonpregnant women: reliability of sialidase detection. Infectious Diseases in Obstetrics and Gynecology, 2001(), 17-22. https://doi.org/10.1155/S1064744901000047
- Eckert, L. O., Moore, D. E., Patton, D. L., Agnew, K. J., & Eschenbach, D. A. (2003). Relationship of vaginal bacteria and inflammation with conception and early pregnancy loss following in-vitro fertilization. Infectious Diseases in Obstetrics and Gynecology, 2003(), 11-17. https://doi.org/10.1155/S1064744903000024
- Sadeghi, M., Namjouyan, F., Cheraghian, B., & Abbaspoor, Z. (2020). Impact of Glycyrrhiza glabra (licorice) vaginal cream on vaginal signs and symptoms of vaginal atrophy in postmenopausal women: A randomized double blind controlled trial. Journal of Traditional and Complementary Medicine, 10(2), 110-115. https://doi.org/10.1016/j.jtcme.2019.02.005
- Mikamo, H., Izumi, K., Ito, K., & Tamaya, T. (1995). Comparative Study of the Effectiveness of Oral Fluconazole and Intravaginal Clotrimazole in the Treatment of Vaginal Candidiasis. Infectious Diseases in Obstetrics and Gynecology, 1995(), 7-11. https://doi.org/10.1155/S1064744995000238